EW Edwards Lifesciences
NYSE · SEC CIK 1099800 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $27.68M 42 sales by 9 insiders
- Filings on record
- 445 since 2021-07-01, latest 2026-09-14 18:04
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| BOBO DONALD E JR | CVP, Strategy, Corp Development | — | $11.15M |
| Zovighian Bernard J | CEO, Dir | — | $7.00M |
| Ullem Scott B. | CFO, CVP | — | $3.87M |
| Chopra Daveen | CVP, TMTT, Surgical, IHFM | — | $3.19M |
| Markowitz Wayne | CVP, JAPAC | — | $1.04M |
| Lippis Daniel J. | CVP, TAVR | — | $871.6K |
| Bruls Annette | CVP, EMEACLA | — | $237.9K |
| STONE HEISZ LESLIE | Dir | — | $218.1K |
| Dahl Andrew M. | SVP, Corp. Ctrl | — | $98.4K |
| Davis Leslie C. | Dir | — | — |
Transactions 820
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-13 | 2025-03-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $67.96 | -9,500 | 46.9K | -17% | -$645.6K |
| D | 2025-03-10 | 2025-03-10 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | -1,299 | 65.2K | -2% | $0 |
| D | 2025-03-10 | 2025-03-10 | EW | Zovighian Bernard J | CEO, Dir | S - Sale+OE | $69.51 | -6,164 | 59.1K | -9% | -$428.5K |
| DI | 2025-03-10 | 2025-03-10 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | +1,299 | 10.4K | +14% | $0 |
| D | 2025-03-10 | 2025-03-10 | EW | Zovighian Bernard J | CEO, Dir | M - OptEx | $45.28 | +7,463 | 66.5K | +13% | +$337.9K |
| D | 2025-03-10 | 2025-03-10 | EW | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $69.48 | -400 | 22.6K | -2% | -$27.8K |
| D | 2025-03-10 | 2025-03-10 | EW | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +400 | 23.0K | +2% | +$18.1K |
| DM | 2025-02-28 | 2025-02-28 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $70.79 | -11.2K | 30.4K | -27% | -$796.4K |
| D | 2025-02-28 | 2025-02-28 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $45.28 | +11.2K | 41.6K | +37% | +$509.4K |
| 2025-02-24 | 2025-02-22 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | F - Tax | $73.30 | -176 | 4,684 | -4% | -$12.9K | |
| 2025-02-18 | 2025-02-16 | EW | Ullem Scott B. | CFO, CVP | F - Tax | $76.19 | -174 | 30.4K | -0.6% | -$13.3K | |
| M | 2025-02-18 | 2025-02-16+ | EW | Lippis Daniel J. | CVP, JAPAC | F - Tax | $76.19 | -601 | 22.6K | -3% | -$45.8K |
| 2025-02-18 | 2025-02-16 | EW | Wood Larry L | Gbl Pres TAVR, Surg | F - Tax | $76.19 | -333 | 198.2K | -0.2% | -$25.4K | |
| D | 2025-02-14 | 2025-02-14 | EW | LORANGER STEVEN R | Dir | M - OptEx | $45.32 | +5,739 | 66.1K | +10% | +$260.1K |
| D | 2025-02-14 | 2025-02-14 | EW | LORANGER STEVEN R | Dir | S - Sale+OE | $76.42 | -5,739 | 60.4K | -9% | -$438.6K |
| DM | 2025-02-13 | 2025-02-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $75.75 | -6,500 | 53.3K | -11% | -$492.4K |
| D | 2025-02-13 | 2025-02-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $45.28 | +6,500 | 53.4K | +14% | +$294.3K |
| D | 2025-02-13 | 2025-02-13 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $45.28 | +11.2K | 41.8K | +37% | +$509.4K |
| D | 2025-02-13 | 2025-02-13 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $75.76 | -11.2K | 30.6K | -27% | -$852.3K |
| D | 2025-02-13 | 2025-02-13 | EW | STONE HEISZ LESLIE | Dir | M - OptEx | $45.32 | +5,739 | 35.8K | +19% | +$260.1K |
| D | 2025-02-13 | 2025-02-13 | EW | STONE HEISZ LESLIE | Dir | S - Sale+OE | $75.86 | -5,739 | 30.0K | -16% | -$435.4K |
| D | 2025-02-13 | 2025-02-13 | EW | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +500 | 23.7K | +2% | +$22.6K |
| D | 2025-02-13 | 2025-02-13 | EW | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $76.34 | -500 | 23.2K | -2% | -$38.2K |
| D | 2025-01-16 | 2025-01-16 | EW | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $68.76 | -500 | 23.2K | -2% | -$34.4K |
| D | 2025-01-16 | 2025-01-16 | EW | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +500 | 23.7K | +2% | +$22.6K |
| D | 2025-01-16 | 2025-01-16 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $45.28 | +5,000 | 51.9K | +11% | +$226.4K |
| D | 2025-01-16 | 2025-01-16 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $68.75 | -5,000 | 46.9K | -10% | -$343.8K |
| D | 2024-12-16 | 2024-12-16 | EW | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $74.08 | -2,500 | 23.2K | -10% | -$185.2K |
| D | 2024-12-16 | 2024-12-16 | EW | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +2,500 | 25.7K | +11% | +$113.2K |
| D | 2024-12-09 | 2024-12-09 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $45.28 | +5,000 | 51.9K | +11% | +$226.4K |
| D | 2024-12-09 | 2024-12-09 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $71.75 | -5,000 | 46.9K | -10% | -$358.8K |
| D | 2024-12-09 | 2024-12-09 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $71.68 | -11.2K | 30.6K | -27% | -$806.4K |
| D | 2024-12-09 | 2024-12-09 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $45.28 | +11.2K | 41.8K | +37% | +$509.4K |
| 2024-12-06 | 2024-12-06 | EW | Markowitz Wayne | SVP, GM, Surgical | S - Sale | $73.27 | -583 | 9,494 | -6% | -$42.7K | |
| 2024-12-06 | 2024-12-06 | EW | Chopra Daveen | CVP, TMTT | S - Sale | $73.27 | -1,750 | 27.6K | -6% | -$128.2K | |
| D | 2024-11-13 | 2024-11-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $65.57 | -5,000 | 46.9K | -10% | -$327.8K |
| D | 2024-11-13 | 2024-11-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $45.28 | +5,000 | 51.9K | +11% | +$226.4K |
| 2024-11-05 | 2024-11-05 | EW | Wood Larry L | Gbl Pres TAVR, Surg | S - Sale | $65.91 | -25.0K | 198.5K | -11% | -$1.65M | |
| D | 2024-10-15 | 2024-10-15 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $69.51 | -5,000 | 46.9K | -10% | -$347.6K |
| D | 2024-10-15 | 2024-10-15 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $45.28 | +5,000 | 51.9K | +11% | +$226.4K |
| 2024-09-16 | 2024-09-13 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | A - Grant | $0.00 | +2,920 | 4,691 | +165% | $0 | |
| 2024-09-16 | 2024-09-14 | EW | Markowitz Wayne | SVP, GM, Surgical | F - Tax | $68.52 | -648 | 10.0K | -6% | -$44.4K | |
| D | 2024-09-11 | 2024-09-11 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $45.28 | +5,000 | 51.9K | +11% | +$226.4K |
| D | 2024-09-11 | 2024-09-11 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $66.77 | -5,000 | 46.9K | -10% | -$333.9K |
| 2024-09-03 | 2024-09-03 | EW | Szyman Catherine M. | CVP, Critical Care | A - Grant | $0.00 | +10.9K | 86.8K | +14% | $0 | |
| 2024-09-03 | 2024-09-03 | EW | Szyman Catherine M. | CVP, Critical Care | F - Tax | $69.96 | -5,530 | 81.3K | -6% | -$386.9K | |
| 2024-08-20 | 2024-08-20 | EW | Chopra Daveen | CVP, TMTT | S - Sale | $69.95 | -1,250 | 29.3K | -4% | -$87.4K | |
| D | 2024-08-14 | 2024-08-14 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $45.28 | +5,000 | 51.9K | +11% | +$226.4K |
| D | 2024-08-14 | 2024-08-14 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $66.08 | -5,000 | 46.9K | -10% | -$330.4K |
| D | 2024-07-11 | 2024-07-11 | EW | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $94.18 | -500 | 23.2K | -2% | -$47.1K |
| D | 2024-07-11 | 2024-07-11 | EW | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +500 | 23.7K | +2% | +$22.6K |
| 2024-07-10 | 2024-07-10 | EW | Feinberg David T | Dir | A - Grant | $0.00 | +2,308 | 2,308 | New | $0 | |
| D | 2024-07-10 | 2024-07-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $45.28 | +5,000 | 51.9K | +11% | +$226.4K |
| D | 2024-07-10 | 2024-07-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $93.29 | -5,000 | 46.9K | -10% | -$466.5K |
| 2024-07-08 | 2024-07-07 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $92.32 | -82 | 184.7K | -0.0% | -$7,570 | |
| 2024-07-08 | 2024-07-07 | EW | Lippis Daniel J. | CVP, JAPAC | F - Tax | $92.32 | -410 | 23.2K | -2% | -$37.9K | |
| 2024-07-08 | 2024-07-07 | EW | Szyman Catherine M. | CVP, Critical Care | F - Tax | $92.32 | -258 | 75.9K | -0.3% | -$23.8K | |
| D | 2024-06-20 | 2024-06-20 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $45.28 | +5,625 | 36.2K | +18% | +$254.7K |
| DM | 2024-06-20 | 2024-06-20 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $87.52 | -5,625 | 30.6K | -16% | -$492.3K |
| D | 2024-06-20 | 2024-06-20 | EW | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +535 | 24.0K | +2% | +$24.2K |
| D | 2024-06-20 | 2024-06-20 | EW | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $90.00 | -535 | 23.5K | -2% | -$48.1K |
| D | 2024-06-12 | 2024-06-12 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $45.28 | +5,000 | 51.9K | +11% | +$226.4K |
| D | 2024-06-12 | 2024-06-12 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $87.54 | -5,000 | 46.9K | -10% | -$437.7K |
| 2024-05-30 | 2024-05-30 | EW | Zovighian Bernard J | CEO, Dir | S - Sale | $87.68 | -8,617 | 68.2K | -11% | -$755.5K | |
| D | 2024-05-21 | 2024-05-21 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $45.28 | +5,625 | 36.2K | +18% | +$254.7K |
| D | 2024-05-21 | 2024-05-21 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $90.45 | -5,625 | 30.6K | -16% | -$508.8K |
| 2024-05-13 | 2024-05-11 | EW | Wood Larry L | Gbl Pres TAVR, Surg | F - Tax | $86.72 | -985 | 223.5K | -0.4% | -$85.4K | |
| 2024-05-13 | 2024-05-11 | EW | Lippis Daniel J. | CVP, JAPAC | F - Tax | $86.72 | -377 | 23.5K | -2% | -$32.7K | |
| 2024-05-13 | 2024-05-11 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $86.72 | -21 | 184.8K | -0.0% | -$1,821 | |
| 2024-05-13 | 2024-05-11 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | F - Tax | $86.72 | -229 | 17.1K | -1% | -$19.9K | |
| 2024-05-13 | 2024-05-11 | EW | Ullem Scott B. | CFO, CVP | F - Tax | $86.72 | -1,198 | 30.6K | -4% | -$103.9K | |
| D | 2024-05-13 | 2024-05-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $45.28 | +5,000 | 52.7K | +10% | +$226.4K |
| D | 2024-05-13 | 2024-05-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $87.81 | -5,000 | 47.7K | -9% | -$439.1K |
| D | 2024-05-13 | 2024-05-11 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | F - Tax | $86.72 | -814 | 46.9K | -2% | -$70.6K |
| 2024-05-13 | 2024-05-11 | EW | Chopra Daveen | CVP, TMTT | F - Tax | $86.72 | -821 | 30.6K | -3% | -$71.2K | |
| 2024-05-13 | 2024-05-11 | EW | Zovighian Bernard J | CEO, Dir | F - Tax | $86.72 | -2,854 | 76.8K | -4% | -$247.5K | |
| 2024-05-13 | 2024-05-11 | EW | Szyman Catherine M. | CVP, Critical Care | F - Tax | $86.72 | -827 | 76.2K | -1% | -$71.7K | |
| 2024-05-09 | 2024-05-07 | EW | Szyman Catherine M. | CVP, Critical Care | F - Tax | $85.09 | -609 | 77.0K | -0.8% | -$51.8K | |
| 2024-05-09 | 2024-05-07 | EW | Szyman Catherine M. | CVP, Critical Care | A - Grant | $0.00 | +32.0K | 77.6K | +70% | $0 | |
| D | 2024-05-09 | 2024-05-07 | EW | Markowitz Wayne | SVP, GM, Surgical | A - Grant | $0.00 | +3,350 | 10.6K | +46% | $0 |
| 2024-05-09 | 2024-05-08 | EW | STONE HEISZ LESLIE | Dir | A - Grant | $0.00 | +3,055 | 30.0K | +11% | $0 | |
| M | 2024-05-09 | 2024-05-08 | EW | LORANGER STEVEN R | Dir | A - Grant | $0.00 | +4,054 | 59.4K | +7% | $0 |
| DM | 2024-05-09 | 2024-05-07 | EW | Lippis Daniel J. | CVP, JAPAC | A - Grant | $0.00 | +7,560 | 24.5K | +45% | $0 |
| D | 2024-05-09 | 2024-05-07 | EW | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $85.60 | -857 | 23.9K | -3% | -$73.4K |
| D | 2024-05-09 | 2024-05-07 | EW | Lippis Daniel J. | CVP, JAPAC | F - Tax | $85.09 | -586 | 24.7K | -2% | -$49.9K |
| D | 2024-05-09 | 2024-05-07 | EW | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $36.75 | +857 | 25.3K | +4% | +$31.5K |
| D | 2024-05-09 | 2024-05-07 | EW | Zovighian Bernard J | CEO, Dir | F - Tax | $85.09 | -647 | 79.7K | -0.8% | -$55.1K |
| D | 2024-05-09 | 2024-05-07 | EW | Zovighian Bernard J | CEO, Dir | A - Grant | $0.00 | +33.5K | 80.3K | +72% | $0 |
| 2024-05-09 | 2024-05-08 | EW | Sequeira Ramona | Dir | A - Grant | $0.00 | +3,055 | 8,158 | +60% | $0 | |
| M | 2024-05-09 | 2024-05-08 | EW | GALLAHUE KIERAN | Dir | A - Grant | $0.00 | +4,054 | 3,055 | New | $0 |
| D | 2024-05-09 | 2024-05-07 | EW | Chopra Daveen | CVP, TMTT | F - Tax | $85.09 | -447 | 31.4K | -1% | -$38.0K |
| D | 2024-05-09 | 2024-05-07 | EW | Chopra Daveen | CVP, TMTT | A - Grant | $0.00 | +7,000 | 31.9K | +28% | $0 |
| 2024-05-09 | 2024-05-08 | EW | VALERIANI NICHOLAS J | Dir | A - Grant | $0.00 | +4,818 | 73.7K | +7% | $0 | |
| D | 2024-05-09 | 2024-05-07 | EW | Ullem Scott B. | CFO, CVP | A - Grant | $0.00 | +11.1K | 32.5K | +52% | $0 |
| D | 2024-05-09 | 2024-05-07 | EW | Ullem Scott B. | CFO, CVP | F - Tax | $85.09 | -790 | 31.8K | -2% | -$67.2K |
| D | 2024-05-09 | 2024-05-07 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $85.09 | -46 | 184.8K | -0.0% | -$3,914 |
| D | 2024-05-09 | 2024-05-07 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | A - Grant | $0.00 | +7,125 | 184.8K | +4% | $0 |
| 2024-05-09 | 2024-05-08 | EW | LAVIOLETTE PAUL A | Dir | A - Grant | $0.00 | +3,055 | 10.8K | +40% | $0 | |
| 2024-05-09 | 2024-05-08 | EW | Davis Leslie C. | Dir | A - Grant | $0.00 | +3,055 | 3,055 | New | $0 | |
| D | 2024-05-09 | 2024-05-07 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | A - Grant | $0.00 | +2,445 | 17.5K | +16% | $0 |
Purchase Sale Sale after option exercise All abbreviations